Cell — engineering firm MaxCyte's Q3 revenue beats; annual outlook lifted
(This story was generated using AI and automation, please see disclaimer ) Overview Cell-engineering firm's preliminary Q3 revenue rose 26% yr/yr, beating analyst expectations Company raised full-year 2026 revenue guidance to about $34 mln Q3 results driven by accelerated instrument purchasing from a large customer Out